Literature DB >> 2530776

Paroxetine plasma levels: lack of correlation with efficacy or adverse events.

T C Tasker1, C M Kaye, B D Zussman, C G Link.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2530776     DOI： 10.1111/j.1600-0447.1989.tb07201.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN： 0065-1591


× No keyword cloud information.
  21 in total

Review 1.  Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.

Authors:  M J Burke; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

Review 2.  Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  C L DeVane
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

Review 3.  The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.

Authors:  Norbert Thuerauf; Jens Lunkenheimer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

4.  "There is no dose-response relationship in psychopharmacotherapy" vs "pharmacotherapy in psychiatry is based on ligand-receptor interaction": a unifying hypothesis and the need for plasma concentration based clinical trials.

Authors:  Vincent Eggart; Christoph Hiemke; Gerald Zernig
Journal:  Psychopharmacology (Berl)       Date:  2011-05-04       Impact factor: 4.530

Review 5.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 6.  Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Authors:  P Baumann
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of darunavir.

Authors:  Michael Rittweger; Keikawus Arastéh
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 8.  Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

Authors:  S M Holliday; G L Plosker
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

9.  Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.

Authors:  Francis E Lotrich; Bruce G Pollock; Margaret Kirshner; Robert F Ferrell; Charles F Reynolds Iii
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

Review 10.  Clinical pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  J van Harten
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.